Literature DB >> 12867406

Nasolacrimal outflow drainage anomalies in Down's syndrome.

David K Coats1, Kathryn M Brady McCreery, David A Plager, Lisa Bohra, Dong Seob Kim, Evelyn A Paysse.   

Abstract

PURPOSE: To describe structural abnormalities of the lacrimal drainage system and outcomes after treatment for lacrimal outflow obstruction in children with Down's syndrome.
DESIGN: Retrospective comparative interventional case series. PARTICIPANTS: Thirty-eight eyes of 22 consecutive Down's syndrome patients who underwent surgical treatment for nasolacrimal drainage obstruction (mean age, 32 months) and 59 eyes of 44 non-Down's syndrome patients who underwent surgical treatment after 2 years of age. MAIN OUTCOME MEASURES: Resolution of symptoms after surgery and presence of anatomic abnormalities of the lacrimal drainage system other than persistent Hasner's membrane.
RESULTS: Among the Down's syndrome eyes, complete or partial resolution was noted in 34 (89%) of 38 eyes; 7 (18%) eyes underwent more than 1 procedure. Twenty-eight (74%) of 38 eyes had anatomic anomalies other than persistent Hasner's membrane; anomalies proximal to the nasolacrimal sac predominated. In comparison, 50 (85%) non-Down's syndrome eyes experienced complete or partial resolution, and 19 (32%) had anatomic abnormalities other than persistent Hasner's membrane; anomalies distal to the nasolacrimal sac predominated.
CONCLUSIONS: Compared with older non-Down's syndrome patients, nasolacrimal outflow obstruction in Down's syndrome patients is more often complicated by anomalies of the lacrimal drainage system proximal to the lacrimal sac. Despite this, surgery can be similarly successful. Awareness of the possible peculiarities of lacrimal outflow obstruction in Down's syndrome patients may allow better selection and use of available treatment options.

Entities:  

Mesh:

Year:  2003        PMID: 12867406     DOI: 10.1016/S0161-6420(03)00410-X

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  8 in total

1.  Paediatric powered endonasal dacryocystorhinostomy.

Authors:  Dania Al-Nuaimi; Clare Inkster; Christopher Lobo
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-04-26       Impact factor: 2.503

2.  Congenital lacrimal fistula associated with Down syndrome.

Authors:  Sangmoon Lee; Namju Kim; Sang In Khwarg; Ho-Kyung Choung; Min Joung Lee
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-06-17       Impact factor: 3.117

3.  Corneal Morphologic Characteristics in Patients With Down Syndrome.

Authors:  Jorge L Alio; Alfredo Vega-Estrada; Pablo Sanz; Amr A Osman; Ahmed M Kamal; Amr Mamoon; Hany Soliman
Journal:  JAMA Ophthalmol       Date:  2018-09-01       Impact factor: 7.389

4.  High-resolution dacryoendoscopy for observation for pediatric lacrimal duct obstruction.

Authors:  Nozomi Matsumura; Satoshi Goto; Shin Yamane; Takeshi Fujita; Maiko Inoue; Mikio Inamura; Kazuaki Kadonosono
Journal:  Am J Ophthalmol Case Rep       Date:  2016-03-21

5.  Success rates of probing for congenital nasolacrimal duct obstruction at various ages.

Authors:  Marta Świerczyńska; Ewelina Tobiczyk; Piotr Rodak; Dorota Barchanowska; Erita Filipek
Journal:  BMC Ophthalmol       Date:  2020-10-08       Impact factor: 2.209

Review 6.  Down syndrome: a review of ocular manifestations.

Authors:  Abid Haseeb; Elisah Huynh; Reem H ElSheikh; Ahmed S ElHawary; Christina Scelfo; Danielle M Ledoux; Daniel E Maidana; Abdelrahman M Elhusseiny
Journal:  Ther Adv Ophthalmol       Date:  2022-06-30

Review 7.  Systemic and ocular manifestations of a patient with mosaic ARID1A-associated Coffin-Siris syndrome and review of select mosaic conditions with ophthalmic manifestations.

Authors:  Virginia Miraldi Utz; Diana S Brightman; Monica A Sandoval; Robert B Hufnagel; Howard M Saal
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-09-05       Impact factor: 3.359

8.  Rare case of nasolacrimal duct opening into face.

Authors:  Bibhuti Bhusan Nayak; Nilamani Mohanty; Annada Prasad Patnaik
Journal:  Indian J Plast Surg       Date:  2013-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.